{"id":"W4414813522","doi":"10.1007/s10120-025-01660-4","title":"Comparative efficacy and safety of tislelizumab and other programmed cell death protein 1 inhibitors in first-line treatment of advanced gastroesophageal cancers: a systematic review and network meta-analysis","year":2025,"lang":"en","type":"review","venue":"Gastric Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Pembrolizumab; Nivolumab; Chemotherapy; Programmed cell death 1; Adverse effect; Incidence (geometry); Surgical oncology; Gastroesophageal Junction","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01106017,0.002022775,0.0132792,0.005554061,0.0003759791,0.002314797,0.001714631,0.001538926,0.002883671],"category_scores_gemma":[0.02283219,0.0009320261,0.03037975,0.005694181,0.0005169127,0.001280206,0.001036579,0.001429057,0.0002310839],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002259544,"about_ca_system_score_gemma":0.002672463,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005203702,"about_ca_topic_score_gemma":0.01085839,"domain_scores_codex":[0.992867,0.003680689,0.001645779,0.0008163974,0.0008001503,0.0001900607],"domain_scores_gemma":[0.9875564,0.00890681,0.002156565,0.0003170452,0.000894503,0.0001686745],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.002403745,0.0000313838,0.003148765,0.3064263,0.6722364,0.00007871548,0.00005383551,0.00100249,0.0002383398,0.0001729345,0.0006379576,0.013569],"study_design_scores_gemma":[0.0007294667,0.0002021001,0.002639217,0.01609894,0.9783171,0.00006316097,0.00002390587,0.000337173,0.00009280432,0.0002521512,0.001224618,0.00001930337],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00638528,0.9909647,0.000798701,0.0002426052,0.0001338273,0.0002877016,0.0008304483,0.00002247709,0.0003342927],"genre_scores_gemma":[0.2660021,0.7261598,0.003063337,0.00105392,0.0002547222,0.001396485,0.001608312,0.00003327475,0.0004281666],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0132792,"threshold_uncertainty_score":0.05849254,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06392817142680882,"score_gpt":0.3591512268560754,"score_spread":0.2952230554292666,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}